Скачать или смотреть From Biosimilars to Cell & Gene Therapy | India’s Biotech Evolution | Biotech Stage's podcast

Welcome to Biotech Stage, the global platform where we talk with leading biotechnology professionals about the latest innovations, opportunities, and challenges in the life sciences world.

In this episode, host Dr. Arun Singhal speaks with Dr. Ravish Patel, General Manager of Technical Operations at Kudo Life Sciences, who shares his fascinating journey across India’s top biotech companies — Cipla, Sun Pharma, Intas, and Kudo.

Dr. Patel discusses:

His transition from biosimilars to cell and gene therapy (CGT)

The evolution of India’s biotech ecosystem

The growing importance of plasmid DNA in mRNA vaccines and gene editing

Differences between startup and large pharma culture

Key challenges in CGT manufacturing and regulation

Valuable career advice for young scientists in biotechnology

Stay tuned until the end for a rapid-fire round on India’s biotech industry performance and future outlook.

📌 Host: Dr. Arun Singhal
🎙️ Guest: Dr. Ravish Patel, General Manager – Technical Operations, Kudo Life Sciences
🔔 Subscribe for more insightful biotech conversation

Follow us on
Website:
https://biotechstage.com
Linkedin:
  / arun-singhal-b4292a1b  

#BiotechPodcast #CellCulture #Biopharma #BiotechLeadership #Bioprocessing #LifeSciencesCareers #BiotechIndia #GeneTherapy #BiotechStage
#biotech #podcast #Lifesciencespodcast, #innovationinscience, #biopharmatalks, #Biosimilartalks, #Mabs, #bioproduction